Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

AstraZeneca's Imfinzi plus Lynparza effective for endometrial cancer

26th May 2023 08:14

(Alliance News) - AstraZeneca PLC on Friday said that its most recent trial testing Imfinzi showed that the therapy significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy. Read More

LONDON BRIEFING: UK retail sales up; Hunt "comfortable" with recession

26th May 2023 07:57

(Alliance News) - Stocks in London are expected to kick off the final trading day of a fraught week with a minor gain, though US debt ceiling uncertainty continues to temper sentiment. Read More

IN BRIEF: AstraZeneca hires LSEG CFO Anna Manz as non-exec director

22nd May 2023 08:42

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Hires Chief Financial Officer Anna Manz of London Stock Exchange Group PLC as a non-executive director from September 1. Manz joined the price data, trading and clearing systems operator in November 2020 as CFO. She was CFO of speciality chemicals Johnson Matthey PLC from 2016 to 2020. Prior to that, Manz spent 17 years at London-based brewer and distiller Diageo PLC in a number of senior finance roles, Astra noted. Read More

AstraZeneca's Tagrisso plus chemotherapy effective against lung cancer

17th May 2023 09:53

(Alliance News) - AstraZeneca PLC on Wednesday said its Tagrisso, used together with chemotherapy, showed improvement in progression-free survival for patients with lung cancer. Read More

AstraZeneca's Ultomiris approved in EU for autoimmune disease NMOSD

10th May 2023 08:50

(Alliance News) - AstraZeneca PLC on Wednesday said the European Commission approved its drug Ultomiris in the EU for adults with autoimmune disease neuromyelitis optica spectrum disorder, known as NMOSD. Read More

LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK

9th May 2023 09:29

(Alliance News) - The following London-listed shares received analyst recommendations xxxxday morning: Read More

TOP NEWS: AstraZeneca's Farxiga approved in US to treat heart failure

9th May 2023 09:09

(Alliance News) - AstraZeneca PLC on Tuesday said its Farxiga drug has been approved by the US Food & Drug Administration to reduce the risk of cardiovascular death and hospitalisation for heart failure in adults. Read More

IN BRIEF: AstraZeneca Chair Michel Demare buys GBP230,000 in shares

2nd May 2023 14:28

AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Non-Executive Chair Michel Demare buys 2,000 shares at GBP117.01, worth GBP234,020, on Friday last week. Read More

AstraZeneca bemoans ODAC judgement on use of Lynparza drug for cancer

2nd May 2023 09:06

(Alliance News) - AstraZeneca PLC on Tuesday bemoaned the results of a regulatory meeting held by the US Food & Drug Administration, which suggested its Lynparza prostate cancer treatment should be limited to tumours with a BRCA mutation. Read More

AstraZeneca "disappointed" with US ODAC's guidance on Lynparza

1st May 2023 12:35

(Alliance News) - AstraZeneca PLC on Friday said the US Food & Drug Administration's Oncologic Drugs Advisory Committee has recognised a favourable benefit risk profile for its Lynparza, plus abiraterone and prednisone or prednisolone, for the treatment of adult patients with BRCA-mutated metastatic castration-resistant prostate cancer. Read More

TOP NEWS: AstraZeneca profit jumps despite Covid-19 sales decline

27th Apr 2023 09:26

(Alliance News) - AstraZeneca PLC on Thursday said revenue decreased in the first quarter of the year as Covid-19 related sales dropped, but pretax profit surged. Read More

LONDON MARKET OPEN: Stocks lower amid worries for health of US economy

27th Apr 2023 09:05

(Alliance News) - Stock prices in London opened lower on Thursday, with the FTSE 100 failing to get a boost by positive first-quarter results from major constituents including Barclays and AstraZeneca. Read More

LONDON BRIEFING: AstraZeneca revenue dips as Covid medicines decline

27th Apr 2023 07:52

(Alliance News) - Stocks in London were set to open lower on Thursday, as investors concern continued to mount about the health of the US banking sector after another largely lower finish in New York. Read More

LONDON MARKET CLOSE: Tech shines but tepid trade elsewhere

26th Apr 2023 17:03

(Alliance News) - European equities closed lower on Wednesday, with lingering banking sector worries hurting sentiment, while tech stocks outperformed wider markets in New York after well-received earnings overnight. Read More

UK earnings, trading statements calendar - next 7 days

20th Apr 2023 15:41

UK shareholder meetings calendar - next 7 days

20th Apr 2023 15:39

LONDON BRIEFING: Possible offers for Network International, John Wood

17th Apr 2023 07:52

(Alliance News) - Stock prices in London were called higher on Monday, following Asian equities into the green. Read More

AstraZeneca reports positive results for lung cancer drug combination

17th Apr 2023 06:45

(Alliance News) - AstraZeneca PLC on Sunday announced that a phase three trial showed that its Imfinzi treatment, in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery, had positive results in non-small cell lung cancer. Read More

TOP NEWS: AstraZeneca Covid antibody neutralises variants of concern

14th Apr 2023 08:24

(Alliance News) - AstraZeneca PLC on Friday said that its investigational Covid long-acting antibody AZD3152 neutralises all known variants of concern. Read More

LONDON BROKER RATINGS: Redburn likes Shell; Barclays raises Persimmon

11th Apr 2023 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday and over the long Easter weekend: Read More

FTSE 100 Latest

Value9,491.25

Change63.52